Respiri Limited, an e-health SaaS company, researches, develops, and commercializes medical devices in Australia. The company develops, produces, and sells mobile health applications. Its products include wheezo, an electronic wheeze detection tool to detect wheeze in children; respiri mobile application; and Respiri health portal. The company was formerly known as iSonea Limited and changed its name to Respiri Limited in December 2015. The company is based in Melbourne, Australia.
Stock data | 2023 | Change |
---|---|---|
Price | $0.01745856947167683 | N/A |
Market Cap | $14.08M | N/A |
Shares Outstanding | 806.46M | 10.68% |
Employees | 0 | N/A |
Shareholder Equity | 826.89K | -72.51% |
Valuation | 2023 | Change |
---|---|---|
P/E Ratio | -2.42 | N/A |
P/S Ratio | 297.28 | N/A |
P/B Ratio | 17.03 | N/A |
Growth | 2023 | Change |
---|---|---|
Return on Equity | -4.6899 | N/A |
Earnings | 2023 | Change |
---|---|---|
Revenue | $47.36K | N/A |
Earnings | -$3.88M | N/A |
EPS | -0.0072 | N/A |
Earnings Yield | -0.4124 | N/A |
Gross Margin | 0.0699 | N/A |
Operating Margin | -90.06 | N/A |
Net income margin | -81.88 | N/A |
Financial Strength | 2023 | Change |
---|---|---|
Total Assets | $2.14M | N/A |
Total Debt | $100.14K | N/A |
Cash on Hand | $98.15K | N/A |
Debt to Equity | $1.91 | 615.13% |
Cash to Debt | 0.9801 | N/A |
Current Ratio | $1.34 | -61.00% |